Retrograde rotational thrombectomy with the Rotarex® catheter system: treatment option for an acute thrombotic occlusion of a subclavian artery

Abstract

Purpose:The Rotarex® catheter system is an effective tool for endovascular therapy of acute occluded arteries of the lower extremities, especially for the femoral artery. The authors report the use of the Rotarex catheter system for retrograde percutaneous thrombectomy of an occluded subclavian artery.Case presentation:A 79-year-old male patient was referred because of acute pain and paleness of his left arm. Ultrasound examination and computed tomography angiography proved an occlusion of the left subclavian artery from the origin of the vessel. A retrograde recanalization was attempted using the 6F Rotarex catheter and combined with initiation of a local low-dose lytic therapy. A normal blood flow to the left arm was restored. Follow-up examination 3 months later showed a normal perfusion situation of the left upper extremity.Conclusion:The Rotarex catheter system is an effective tool for endovascular therapy of acute occluded arteries and efficacy is not restricted to the lower extremities.

Evolving evidence for limb threatening ischemia treatment with a mechanical thrombectomy approach – we need to think endovascular

“…The prognosis of clinically severe forms of ischaemia depends on timely initiation of appropriate treatment and earliest possible revascularisation. One of the most extensively analysed devices for mechanical treatment is rotational thrombectomy with the Rotarex Ò catheter system [5][6][7][8][9][10][11][12][13][14][15] for which FDA approval was achieved in 2019.…”

Evolving Evidence for Acute and Subacute Limb Ischemia Treatment With a Purely Mechanical Thrombectomy Approach

“…Since recanalization is not ensured by local thrombolysis, additional or alternative procedures such as purely mechanical thrombectomy must be used ( Table 1). One of the most extensively analyzed devices for mechanical treatment is rotational thrombectomy with the Rotarex catheter system (Straub Medical, Wangs, Switzerland), [4][5][6][7][8][9][10][11][12] for which US Food and Drug Administration approval is expected by the end of 2019.…”